Immunologically Related Pathogens Antigens : Implications for Host Responses Repertoire Is Limited to Cross-Reactive The Human CD 1-Restricted T Cell

[1]  K. Khoo,et al.  Truncated Structural Variants of Lipoarabinomannan in Mycobacterium leprae and an Ethambutol-resistant Strain of Mycobacterium tuberculosis* , 2004, Journal of Biological Chemistry.

[2]  G. De Libero,et al.  Diacylated Sulfoglycolipids Are Novel Mycobacterial Antigens Stimulating CD1-restricted T Cells during Infection with Mycobacterium tuberculosis , 2004, The Journal of experimental medicine.

[3]  I. Wilson,et al.  T Cell Activation by Lipopeptide Antigens , 2004, Science.

[4]  L. Bry,et al.  Mechanism of CD1d-restricted natural killer T cell activation during microbial infection , 2003, Nature Immunology.

[5]  D. Wei,et al.  T Cell Development in Mice Expressing CD1d Directed by a Classical MHC Class II Promoter 1 , 2003, The Journal of Immunology.

[6]  S. Kaufmann,et al.  Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis , 2003, Nature Medicine.

[7]  S. Kaufmann,et al.  T-Cell Responses to CD1-Presented Lipid Antigens in Humans with Mycobacterium tuberculosis Infection , 2003, Infection and Immunity.

[8]  A. Plyusnin,et al.  Cross-Protection against Challenge with Puumala Virus after Immunization with Nucleocapsid Proteins from Different Hantaviruses , 2002, Journal of Virology.

[9]  I. Wilson,et al.  Fine Specificity of TCR Complementarity-Determining Region Residues and Lipid Antigen Hydrophilic Moieties in the Recognition of a CD1-Lipid Complex1 , 2002, The Journal of Immunology.

[10]  L. Teyton,et al.  A Thymic Precursor to the NK T Cell Lineage , 2002, Science.

[11]  R. Locksley,et al.  Regulation of CD1 function and NK1.1(+) T cell selection and maturation by cathepsin S. , 2001, Immunity.

[12]  A. Krensky,et al.  T-cell release of granulysin contributes to host defense in leprosy , 2001, Nature Medicine.

[13]  P. Godowski,et al.  Microbial Lipopeptides Stimulate Dendritic Cell Maturation Via Toll-Like Receptor 21 , 2001, The Journal of Immunology.

[14]  Osamu Takeuchi,et al.  Maturation of Human Dendritic Cells by Cell Wall Skeleton of Mycobacterium bovis Bacillus Calmette-Guérin: Involvement of Toll-Like Receptors , 2000, Infection and Immunity.

[15]  G. Besra,et al.  Cd1b-Mediated T Cell Recognition of a Glycolipid Antigen Generated from Mycobacterial Lipid and Host Carbohydrate during Infection , 2000, The Journal of experimental medicine.

[16]  S. Porcelli,et al.  Evidence for Human CD4+ T Cells in the CD1-Restricted Repertoire: Derivation of Mycobacteria-Reactive T Cells from Leprosy Lesions1 , 2000, The Journal of Immunology.

[17]  S. Kaufmann,et al.  Intersection of Group I CD1 Molecules and Mycobacteria in Different Intracellular Compartments of Dendritic Cells1 , 2000, The Journal of Immunology.

[18]  G. Besra,et al.  CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection , 2000, Nature.

[19]  E. V. van Donselaar,et al.  Self-recognition of CD1 by gamma/delta T cells: implications for innate immunity. , 2000, The Journal of experimental medicine.

[20]  Paul V. Lehmann,et al.  Single-Cytokine-Producing CD4 Memory Cells Predominate in Type 1 and Type 2 Immunity1 , 2000, The Journal of Immunology.

[21]  P. Libby,et al.  CD1 expression in human atherosclerosis. A potential mechanism for T cell activation by foam cells. , 1999, The American journal of pathology.

[22]  S. Porcelli,et al.  CD1 expression by dendritic cells in human leprosy lesions: correlation with effective host immunity. , 1999, Journal of immunology.

[23]  Ian A. Wilson,et al.  Molecular Recognition of Lipid Antigens by T Cell Receptors , 1999, The Journal of experimental medicine.

[24]  Loise M. Francisco,et al.  Immature Dendritic Cells Phagocytose Apoptotic Cells via αvβ5 and CD36, and Cross-present Antigens to Cytotoxic T Lymphocytes , 1998, The Journal of experimental medicine.

[25]  T. Ganz,et al.  An antimicrobial activity of cytolytic T cells mediated by granulysin. , 1998, Science.

[26]  R. Slayden,et al.  Mycolic acids: structure, biosynthesis and physiological functions. , 1998, Progress in lipid research.

[27]  P. Huie,et al.  Subsets of Transgenic T Cells That Recognize CD1 Induce or Prevent Murine Lupus: Role of Cytokines , 1998, The Journal of experimental medicine.

[28]  D. Hafler,et al.  Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes , 1998, Nature.

[29]  B. Reinhold,et al.  Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells. , 1997, Science.

[30]  M. Halloran,et al.  A case-control study of the effectiveness of BCG vaccine for preventing leprosy in Yangon, Myanmar. , 1997, International journal of epidemiology.

[31]  S. Balk,et al.  Requirements for CD1d Recognition by Human Invariant Vα24+ CD4−CD8− T Cells , 1997, The Journal of experimental medicine.

[32]  A. Sette,et al.  Determinants of T cell reactivity to the Mycobacterium leprae GroES homologue. , 1997, Journal of immunology.

[33]  A. Sette,et al.  Differential effects of cytolytic T cell subsets on intracellular infection. , 1997, Science.

[34]  S. Porcelli,et al.  CD1c restricts responses of mycobacteria-specific T cells. Evidence for antigen presentation by a second member of the human CD1 family. , 1996, Journal of immunology.

[35]  S. Porcelli,et al.  A pathway of costimulation that prevents anergy in CD28- T cells: B7- independent costimulation of CD1-restricted T cells , 1995, The Journal of experimental medicine.

[36]  P. Brennan,et al.  CD1-restricted T cell recognition of microbial lipoglycan antigens. , 1995, Science.

[37]  J. Yewdell,et al.  CD1 recognition by mouse NK1+ T lymphocytes. , 1995, Science.

[38]  S. Porcelli,et al.  Recognition of a lipid antigen by GDI-restricted αβ+ T cells , 1994, Nature.

[39]  O. Lantz,et al.  An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans , 1994, The Journal of experimental medicine.

[40]  I. Orme,et al.  Disseminated tuberculosis in interferon gamma gene-disrupted mice , 1993, The Journal of experimental medicine.

[41]  O. Majdic,et al.  CD1 molecule expression on human monocytes induced by granulocyte-macrophage colony-stimulating factor. , 1993, Journal of immunology.

[42]  S. Porcelli,et al.  CDlb restricts the response of human CD4−8−T lymphocytes to a microbial antigen , 1992, Nature.

[43]  D. Alland,et al.  A major T cell antigen of Mycobacterium leprae is a 10-kD heat-shock cognate protein , 1992, The Journal of experimental medicine.

[44]  J. Convit,et al.  Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. , 1991, Science.

[45]  T. Mosmann,et al.  IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. , 1991, Journal of immunology.

[46]  M. Nerenberg,et al.  Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: Role of anti-self (virus) immune response , 1991, Cell.

[47]  H. Pircher,et al.  Ablation of “tolerance” and induction of diabetes by virus infection in viral antigen transgenic mice , 1991, Cell.

[48]  S. Balk,et al.  Recognition of cluster of differentiation 1 antigens by human CD4−CD8>− cytolytic T lymphocyte , 1989, Nature.

[49]  R. Steinman,et al.  An analysis of in vitro T cell responsiveness in lepromatous leprosy , 1985, The Journal of experimental medicine.

[50]  B. Bloom,et al.  Immunological Unresponsiveness in Leprosy , 1984, Immunological reviews.

[51]  E. Reinherz,et al.  Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[52]  R. Webster,et al.  Matrix protein from influenza A virus and its role in cross-protection in mice , 1977, Infection and immunity.

[53]  T. Godal,et al.  Characterization of the cellular immune defect in lepromatous leprosy: a specific lack of circulating Mycobacterium leprae-reactive lymphocytes. , 1971, Clinical and experimental immunology.

[54]  P. Savage,et al.  Multiple defects in antigen presentation and T cell development by mice expressing cytoplasmic tail–truncated CD1d , 2002, Nature Immunology.

[55]  P. McCray,et al.  β-Defensins in Lung Host Defense , 2002 .

[56]  河野 鉄.  CD1d-restricted and TCR-mediated activation of V α14 NKT cells by glycosylceramides , 2000 .

[57]  S. Porcelli,et al.  The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. , 1999, Annual review of immunology.

[58]  E. Grant,et al.  CD1-restricted microbial lipid antigen-specific recognition found in the CD8+ alpha beta T cell pool. , 1999, Journal of immunology.

[59]  S. Chanteau,et al.  Tuberculosis in leprosy patients detected between 1902 and 1991 in French Polynesia. , 1993, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

[60]  K. Weinberg,et al.  Defining protective responses to pathogens: cytokine profiles in leprosy lesions. , 1991, Science.

[61]  C. Janeway.  Approaching the asymptote? Evolution and revolution in immunology. , 1989, Cold Spring Harbor symposia on quantitative biology.

[62]  B. Bloom,et al.  Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions , 1986, Nature.

[63]  D. Ridley,et al.  Classification of leprosy according to immunity. A five-group system. , 1966, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.